Metraipolis › archive › dc_ea064e9d004b

Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy — Europe PMC PMID:42196157

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42196157
DOI
10.3390/ijms27104172
License (as archived)
solo-consultazione
Archived
2026-11-02T15:05:23.551Z
SHA-256 of the archived text
b68e0611bb1004bd3aa6a0846b9a3c704297e8a096a0bd8ae8621bbf77959f2b
Stable URL of this page
https://metraipolis.com/documento/dc_ea064e9d004b

How to cite

Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy — Europe PMC PMID:42196157 — Europe PMC (en), https://europepmc.org/article/MED/42196157 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea064e9d004b (Metraipolis archive dc_ea064e9d004b, sha256 b68e0611bb1004bd3aa6a0846b9a3c704297e8a096a0bd8ae8621bbf77959f2b)
BibTeX
@misc{dcea064e9d004b,
  title = {Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy — Europe PMC PMID:42196157},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42196157},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea064e9d004b; sha256 b68e0611bb1004bd3aa6a0846b9a3c704297e8a096a0bd8ae8621bbf77959f2b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42196157. Agents can read the archived copy with the MCP tool read_document.